Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer

With the high locoregional relapse rate and the improvement of radiation technology, postoperative radiotherapy (PORT) has been widely used in the treatment of completely resected stage IIIA-pN2 non-small-cell lung cancer (NSCLC). However, there is still no definitive consensus on clinical target vo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Xuquan, Meng, Xue, Sun, Xindong, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767117/
https://www.ncbi.nlm.nih.gov/pubmed/26929651
http://dx.doi.org/10.2147/OTT.S98765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767117/
https://www.ncbi.nlm.nih.gov/pubmed/26929651
http://dx.doi.org/10.2147/OTT.S98765

Ejemplares similares